No Detail Found!

Platelet-to-Lymphocyte Ratio as an Indicator to Predict Decreased Carbon Monoxide Di usion of the Lung in Patients with Testicular Cancer

Author(s)
Serdar Karakaya Department of Medical Oncology, Oncology Education and Research Hospital,Ankara,Turkey
Ibrahim Karadag Department of Medical Oncology, Oncology Education and Research Hospital,Ankara,Turkey
Cigdem Ozdilekcan Department of Chest Diseases, Oncology Education and Research Hospital,Ankara,Turkey
Esra Durmusoglu Department of Internal Medicine, Oncology Education and Research Hospital,Ankara,Turkey
Ozturk Ates Department of Medical Oncology, Oncology Education and Research Hospital,Ankara,Turkey
Omur Berna Cakmak Oksuzoglu Department of Medical Oncology, Oncology Education and Research Hospital,Ankara,Turkey
Abstract
Objective: To investigate whether the use of di using capacity of the lungs for carbon monoxide (DLCO) and neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) could be used to predict bleomycin-induced pulmonary toxicity in patients with testicular cancer (TCa). Study Design: Descriptive study. Place and Duration of Study: Ankara Oncology Training and Research Hospital, Turkey, between 2017 and 2020. Methodology: Data of 40 patients with TCa, who were followed at cancer centre from 2017-2020 and received 3-4 cycles of BEP protocol were retrospectively screened and included who met the criteria for inclusion in the study. All patients with TCa, who were older than 18 years of age and had no secondary malignancy and comorbidity, were included in this study. Results: A statistically signi cant negative correlation was found between DLCO change and NLR, PLR (r:-0.558, p:0.002 for NLR; r:-0.462 p:0.012 for PLR). A statistically signi cant positive correlation was found between DLCO change and lymphocyte level (r:0.436, p:0.018). The NLR and PLR were statistically higher in the group with a decrease of e10% in DLCO compared to the group with no decrease or a decrease of d10% in DLCO (for NLR; 3.03 ± 1.45 and 1.68 ± 0.73, respectively, p = 0.005; for PLR 187.72 ± 66.90 and 124.72 ± 47.99, respectively, p = 0.008). Multivariate regression analysis showed a statistically signi cant relationship between PLR increase and a decrease of e10% in DLCO. Conclusion: PLR and LDH could be used as independent predictive biomarkers for DLCO decline which is used to identify bleomycin-induced pulmonary toxicity.
Publication Details
Page(s) 369-372
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
Bleomycin, Platelet-to-lymphocyte ratio (PLR), Testicular cancer, Markers of in ammation, Pulmonary di using capacity
0

Citations

0

Downloads

71

Views